Amylyx Pharmaceuticals, Inc. (AMLX) KPIs and segments

AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30

$30.29+0.43 (+1.44%)

Close on Nov 13, 2026Market cap $3.38BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Amylyx Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to Amylyx Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?